Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

The relative efficiency of time-to-threshold and rate of change in longitudinal data.

Donohue MC, Gamst AC, Thomas RG, Xu R, Beckett L, Petersen RC, Weiner MW, Aisen P; Alzheimer's Disease Neuroimaging Initiative.

Contemp Clin Trials. 2011 Sep;32(5):685-93. doi: 10.1016/j.cct.2011.04.007. Epub 2011 Apr 30.

2.

Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives.

Brookes ST, Whitley E, Peters TJ, Mulheran PA, Egger M, Davey Smith G.

Health Technol Assess. 2001;5(33):1-56. Review.

3.

Physostigmine for Alzheimer's disease.

Coelho F, Birks J.

Cochrane Database Syst Rev. 2001;(2):CD001499. Review.

PMID:
11405996
4.

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2001;(4):CD001747. Review. Update in: Cochrane Database Syst Rev. 2002;(3):CD001747.

PMID:
11687119
5.

Vitamin E for Alzheimer's disease and mild cognitive impairment.

Isaac MG, Quinn R, Tabet N.

Cochrane Database Syst Rev. 2008 Jul 16;(3):CD002854. doi: 10.1002/14651858.CD002854.pub2. Review. Update in: Cochrane Database Syst Rev. 2012;11:CD002854.

PMID:
18646084
6.

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2002;(3):CD001747. Review. Update in: Cochrane Database Syst Rev. 2004;(4):CD001747.

PMID:
12137632
7.

Should we adjust for covariates in nonlinear regression analyses of randomized trials?

Hauck WW, Anderson S, Marcus SM.

Control Clin Trials. 1998 Jun;19(3):249-56. Review.

PMID:
9620808
8.

ECNP consensus meeting. Bipolar depression. Nice, March 2007.

Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.

Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23. Review.

PMID:
18501566
9.

Selegiline for Alzheimer's disease.

Birks J, Flicker L.

Cochrane Database Syst Rev. 2003;(1):CD000442. Review.

PMID:
12535396
10.

Time-dependent covariates in the Cox proportional-hazards regression model.

Fisher LD, Lin DY.

Annu Rev Public Health. 1999;20:145-57. Review.

PMID:
10352854
11.

WITHDRAWN: Tacrine for Alzheimer's disease.

Qizilbash N, Birks J, Lopez Arrieta J, Lewington S, Szeto S.

Cochrane Database Syst Rev. 2007 Jul 18;(3):CD000202. Review.

PMID:
17636619
12.

Galantamine for Alzheimer's disease.

Olin J, Schneider L.

Cochrane Database Syst Rev. 2001;(1):CD001747. Review. Update in: Cochrane Database Syst Rev. 2001;(4):CD001747.

PMID:
11279727
13.

Tacrine for Alzheimer's disease.

Qizilbash N, Birks J, López-Arrieta J, Lewington S, Szeto S.

Cochrane Database Syst Rev. 2000;(2):CD000202. Review. Update in: Cochrane Database Syst Rev. 2000;(3):CD000202.

PMID:
10796507
Items per page

Supplemental Content

Write to the Help Desk